tetrabenazine has been researched along with Amentia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Estevez-Fraga, C; López-Sendón Moreno, JL; Zeun, P | 1 |
| Aoki, N; Baker, M; Boeve, BF; Dickson, DW; Fujioka, S; Parisi, JE; Rademakers, R; Ross, OA; Sanchez-Contreras, M; Sossi, V; Stoessl, AJ; Strongosky, AJ; Tacik, P; Wszolek, ZK | 1 |
| Albin, RL; Burke, JF; Frey, KA; Gilman, S; Giordani, B; Kilbourn, MR; Koeppe, RA | 2 |
| Albin, RL; Bohnen, NI; Frey, KA; Koeppe, RA; Kotagal, V; Müller, ML; Petrou, M | 1 |
| Albin, RL; Frey, KA; Gilman, S; Heumann, M; Joshi, A; Junck, L; Koeppe, RA; Little, R; Liu, S | 1 |
1 review(s) available for tetrabenazine and Amentia
| Article | Year |
|---|---|
Current Methods for the Treatment and Prevention of Drug-Induced Parkinsonism and Tardive Dyskinesia in the Elderly.
Topics: Aged; Dementia; Dyskinesia, Drug-Induced; Humans; Parkinsonian Disorders; Risk Factors; Tardive Dyskinesia; Tetrabenazine; Valine | 2018 |
5 other study(ies) available for tetrabenazine and Amentia
| Article | Year |
|---|---|
A familial form of parkinsonism, dementia, and motor neuron disease: a longitudinal study.
Topics: Aged; Aged, 80 and over; C9orf72 Protein; Dementia; Family Health; Female; Humans; Intercellular Signaling Peptides and Proteins; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Longitudinal Studies; Male; Middle Aged; Motor Neuron Disease; Mutation; Parkinsonian Disorders; Positron-Emission Tomography; Progranulins; Protein Serine-Threonine Kinases; Proteins; Psychiatric Status Rating Scales; Severity of Illness Index; tau Proteins; Technetium Tc 99m Exametazime; Tetrabenazine; Tomography, Emission-Computed, Single-Photon | 2014 |
Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.
Topics: Age of Onset; Aged; Aged, 80 and over; Binding, Competitive; Brain Mapping; Carbon Radioisotopes; Cerebral Cortex; Cerebrovascular Circulation; Cognition Disorders; Dementia; Early Diagnosis; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tetrabenazine | 2010 |
Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography.
Topics: Amyloid; Analysis of Variance; Aniline Compounds; Benzothiazoles; Brain Mapping; Carbon Isotopes; Dementia; Dopamine; Humans; Neurologic Examination; Positron-Emission Tomography; Psychiatric Status Rating Scales; Tetrabenazine; Thiazoles | 2011 |
β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia.
Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Aniline Compounds; Carbon Isotopes; Cross-Sectional Studies; Dementia; Female; Gait Disorders, Neurologic; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Postural Balance; Psychiatric Status Rating Scales; Sensation Disorders; Severity of Illness Index; Tetrabenazine; Thiazoles | 2013 |
11C-DTBZ and 18F-FDG PET measures in differentiating dementias.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbon Radioisotopes; Cerebral Cortex; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Regional Blood Flow; Regression Analysis; Tetrabenazine | 2005 |